7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Zhou QL et al. Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. 2016 Mol Med Rep pmid:27357904
Lu J et al. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. 2016 Exp. Biol. Med. (Maywood) pmid:26908571
Stuss M et al. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2016 Endokrynol Pol pmid:26884284
Gluba-Brzózka A et al. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. 2016 Lipids Health Dis pmid:26843213
Bumdelger B et al. Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. 2016 PLoS ONE pmid:26783750
Melchiorre D et al. Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. 2016 Haematologica pmid:26494839
Chen H et al. [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070039
Kainuma S et al. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. 2016 Mol Med Rep pmid:26935864
Shimazaki E et al. TGF-β and Physiological Root Resorption of Deciduous Teeth. 2016 Int J Mol Sci pmid:28035998
Bolamperti S et al. Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. 2016 Biomed Res Int pmid:27999816
Li Y et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. 2016 J. Genet. pmid:27994198
Gómez-Vaquero C et al. Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. 2016 PLoS ONE pmid:27911913
Zhang L et al. Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis. 2016 Cell. Physiol. Biochem. pmid:27898403
Zhang YY et al. Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. 2016 Chin J Dent Res pmid:27379348
Songia P et al. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. 2016 J. Mol. Cell. Cardiol. pmid:27338002
Li Y et al. OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. 2016 Medicine (Baltimore) pmid:27336899
Dolan EB et al. Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. 2016 J R Soc Interface pmid:27335224
Kassem A et al. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. 2016 PLoS ONE pmid:27311019
Wang JH et al. Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. 2016 Medicine (Baltimore) pmid:27310953
Yamada C et al. TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. 2016 Int. J. Oncol. pmid:27279422

Table of Content